Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1213269-96-5
2. Utreloxastat [inn]
3. Ww8kzk2pzt
4. Ptc857
5. Ptc-857
6. 2,5-cyclohexadiene-1,4-dione, 2,3,5-trimethyl-6-nonyl-
7. Unii-ww8kzk2pzt
8. 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
9. Compound C9 [wo2020081879a2]
10. Compound C9 (wo2020081879a2)
11. Utreloxastat [usan]
12. Schembl1713853
13. Utreloxastat (jan/usan/inn)
14. Chembl5314565
15. Gtpl13260
16. Da-58934
17. Ms-23936
18. Hy-132845
19. Cs-0204152
20. D12510
21. G18378
| Molecular Weight | 276.4 g/mol |
|---|---|
| Molecular Formula | C18H28O2 |
| XLogP3 | 5.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 8 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 34.1 |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 438 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
66
PharmaCompass offers a list of Utreloxastat API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Utreloxastat manufacturer or Utreloxastat supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Utreloxastat manufacturer or Utreloxastat supplier.
PharmaCompass also assists you with knowing the Utreloxastat API Price utilized in the formulation of products. Utreloxastat API Price is not always fixed or binding as the Utreloxastat Price is obtained through a variety of data sources. The Utreloxastat Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Utreloxastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Utreloxastat, including repackagers and relabelers. The FDA regulates Utreloxastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Utreloxastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Utreloxastat supplier is an individual or a company that provides Utreloxastat active pharmaceutical ingredient (API) or Utreloxastat finished formulations upon request. The Utreloxastat suppliers may include Utreloxastat API manufacturers, exporters, distributors and traders.
Utreloxastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Utreloxastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Utreloxastat GMP manufacturer or Utreloxastat GMP API supplier for your needs.
A Utreloxastat CoA (Certificate of Analysis) is a formal document that attests to Utreloxastat's compliance with Utreloxastat specifications and serves as a tool for batch-level quality control.
Utreloxastat CoA mostly includes findings from lab analyses of a specific batch. For each Utreloxastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Utreloxastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Utreloxastat EP), Utreloxastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Utreloxastat USP).
